These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 27507905

  • 21. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
    Kelley L, Swan N, Hughes DJ.
    Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
    [Abstract] [Full Text] [Related]

  • 22. Effects of Increasing Screening Age and Fecal Hemoglobin Cutoff Concentrations in a Colorectal Cancer Screening Program.
    Wieten E, Schreuders EH, Nieuwenburg SA, Hansen BE, Lansdorp-Vogelaar I, Kuipers EJ, Bruno MJ, Spaander MC.
    Clin Gastroenterol Hepatol; 2016 Dec; 14(12):1771-1777. PubMed ID: 27567693
    [Abstract] [Full Text] [Related]

  • 23. Faecal haemoglobin concentration is related to detection of advanced colorectal neoplasia in the next screening round.
    Digby J, Fraser CG, Carey FA, Diament RH, Balsitis M, Steele RJ.
    J Med Screen; 2017 Jun; 24(2):62-68. PubMed ID: 27370211
    [Abstract] [Full Text] [Related]

  • 24. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial.
    Stoop EM, de Haan MC, de Wijkerslooth TR, Bossuyt PM, van Ballegooijen M, Nio CY, van de Vijver MJ, Biermann K, Thomeer M, van Leerdam ME, Fockens P, Stoker J, Kuipers EJ, Dekker E.
    Lancet Oncol; 2012 Jan; 13(1):55-64. PubMed ID: 22088831
    [Abstract] [Full Text] [Related]

  • 25. Single CT colonography versus three rounds of faecal immunochemical test for population-based screening of colorectal cancer (SAVE): a randomised controlled trial.
    Sali L, Ventura L, Mascalchi M, Falchini M, Mallardi B, Carozzi F, Milani S, Zappa M, Grazzini G, Mantellini P.
    Lancet Gastroenterol Hepatol; 2022 Nov; 7(11):1016-1023. PubMed ID: 36116454
    [Abstract] [Full Text] [Related]

  • 26. A New-Generation Fecal Immunochemical Test (FIT) Is Superior to Quaiac-based Test in Detecting Colorectal Neoplasia Among Colonoscopy Referral Patients.
    Vasilyev S, Smirnova E, Popov D, Semenov A, Eklund C, Hendolin P, Paloheimo L, Syrjänen K.
    Anticancer Res; 2015 May; 35(5):2873-80. PubMed ID: 25964570
    [Abstract] [Full Text] [Related]

  • 27. Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.
    van Roon AH, Goede SL, van Ballegooijen M, van Vuuren AJ, Looman CW, Biermann K, Reijerink JC, Mannetje H', van der Togt AC, Habbema JD, van Leerdam ME, Kuipers EJ.
    Gut; 2013 Mar; 62(3):409-15. PubMed ID: 22387523
    [Abstract] [Full Text] [Related]

  • 28. [Colorectal cancer screening in the Netherlands: which faecal occult blood test?].
    Jansen JB, Blankenstein RM, Mulder CJ.
    Ned Tijdschr Geneeskd; 2013 Mar; 157(16):A5744. PubMed ID: 23594870
    [Abstract] [Full Text] [Related]

  • 29. The cost-effectiveness of immunochemical tests for colorectal cancer screening.
    Lejeune C, Le Gleut K, Cottet V, Galimard C, Durand G, Dancourt V, Faivre J.
    Dig Liver Dis; 2014 Jan; 46(1):76-81. PubMed ID: 24012177
    [Abstract] [Full Text] [Related]

  • 30. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H, Tao S.
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [Abstract] [Full Text] [Related]

  • 31. Population-based colorectal cancer screening programmes using a faecal immunochemical test: should faecal haemoglobin cut-offs differ by age and sex?
    Arana-Arri E, Idigoras I, Uranga B, Pérez R, Irurzun A, Gutiérrez-Ibarluzea I, Fraser CG, Portillo I, EUSKOLON Group.
    BMC Cancer; 2017 Aug 29; 17(1):577. PubMed ID: 28851318
    [Abstract] [Full Text] [Related]

  • 32. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening.
    Guittet L, Guillaume E, Levillain R, Beley P, Tichet J, Lantieri O, Launoy G.
    Cancer Epidemiol Biomarkers Prev; 2011 Jul 29; 20(7):1492-501. PubMed ID: 21576271
    [Abstract] [Full Text] [Related]

  • 33. Faecal haemoglobin can define risk of colorectal neoplasia at surveillance colonoscopy in patients at increased risk of colorectal cancer.
    Digby J, Cleary S, Gray L, Datt P, Goudie DR, Steele RJC, Strachan JA, Humphries A, Fraser CG, Mowat C.
    United European Gastroenterol J; 2020 Jun 29; 8(5):559-566. PubMed ID: 32213041
    [Abstract] [Full Text] [Related]

  • 34. Virtual colonoscopy, optical colonoscopy, or fecal occult blood testing for colorectal cancer screening: results of a pilot randomized controlled trial.
    You JJ, Liu Y, Kirby J, Vora P, Moayyedi P.
    Trials; 2015 Jul 09; 16():296. PubMed ID: 26156248
    [Abstract] [Full Text] [Related]

  • 35. Introducing Colorectal Cancer Screening in Romania - Preliminary Results from the Regional Pilot Programs (ROCCAS).
    Manuc M, Diculescu M, Dumitru E, Gheonea DI, Jinga M, Ionita-Radu F, Mergeani D, Udrescu M, Manuc TE, Cotruta B, Ungurean C, Milanesi E, Dobre M, Stefan I, Sanduleanu-Dascalescu S, Gheorghe C.
    J Gastrointestin Liver Dis; 2024 Mar 29; 33(1):37-43. PubMed ID: 38554425
    [Abstract] [Full Text] [Related]

  • 36. Choice of faecal immunochemical test matters: comparison of OC-Sensor and HM-JACKarc, in the assessment of patients at high risk of colorectal cancer.
    Chapman CJ, Banerjea A, Humes DJ, Allen J, Oliver S, Ford A, Hardy K, Djedovic N, Logan RF, Morling JR.
    Clin Chem Lab Med; 2021 Mar 26; 59(4):721-728. PubMed ID: 33112776
    [Abstract] [Full Text] [Related]

  • 37. A Quarter of Participants With Advanced Neoplasia Have Discordant Results From 2-Sample Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Wieten E, de Klerk CM, Lansdorp-Vogelaar I, Bossuyt PM, Dekker E, Spaander MCW.
    Clin Gastroenterol Hepatol; 2020 Jul 26; 18(8):1805-1811.e1. PubMed ID: 31563557
    [Abstract] [Full Text] [Related]

  • 38. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels.
    Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, van der Togt AC, Kuipers EJ, Habbema JD, van Leerdam ME.
    Br J Cancer; 2009 Apr 07; 100(7):1103-10. PubMed ID: 19337257
    [Abstract] [Full Text] [Related]

  • 39. Seasonal variations do not affect the superiority of fecal immunochemical tests over guaiac tests for colorectal cancer screening.
    Chausserie S, Levillain R, Puvinel J, Ferrand O, Ruiz A, Raginel T, Lantieri O, Launoy G, Guittet L.
    Int J Cancer; 2015 Apr 15; 136(8):1827-34. PubMed ID: 25195670
    [Abstract] [Full Text] [Related]

  • 40. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E.
    Gastroenterology; 2017 Aug 15; 153(2):439-447.e2. PubMed ID: 28483499
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.